新冠肺炎的爆发加速了机器人在医疗卫生领域的应用,而我国机器人发展仍处于“婴儿期”。通过对近年来美、日、欧盟、中涉及医疗卫生机器人的相关政策进行分析,发现应用政策差异主要体现在机构设立,项目开展,平台建设,法规伦理研究等四方面。得出结论：机器人在医疗卫生领域具有较强的适应性和十分广阔的应用前景,政府需要在加强顶层设计,面向市场定向开发,大数据平台建立,法规及伦理研究等方向进一步加强探索,抢占“新一代机器人”的技术制高点,以期实现“智慧医疗”的愿景。

The outbreak of COVID-19 pneumonia has accelerated the application of robots in the field of medical and health care, and the development of robots in China is still in "emerging stage". The study analyzes the relevant policies concerning medical and health robots in the United States, Japan, the European Union, and China in recent years, and finds that the differences in policy objectives are mainly manifested in four aspects: institution establishment, project development, platform construction, and legal ethics research. It is concluded that robots have strong adaptability and very broad application prospects in the medical and health field. In order to occupy the commanding heights of the "new generation of robots", the government needs to further strengthen the exploration of top-level design, market-oriented development, the establishment of big data platforms as well as regulations and ethics research, so as to achieve the vision of "smart medical" in the future.

国家社会科学基金一般项目 “政治安全视角下人工智能风险识别与评估研究”(18BZZ091)；华中科技大学新型冠状病毒肺炎应急科技攻关专项“基于综合集成研讨的重大突发公共卫生事件 快速识别与预警机制研究”(2020kfyXGYJ022)